pancreatic cancer genomes reveal aberrations axon guidance pathway genes
pancreatic cancer highly lethal malignancy effective therapies performed exome sequencing copy number analysis define genomic aberrations prospectively accrued clinical cohort n early stage ii sporadic pancreatic ductal adenocarcinoma detailed analysis informative tumours identified substantial heterogeneity non-silent mutations copy-number variations define significantly mutated genes reaffirming known mutations kras tp53 cdkn2a smad4 mll3 tgfbr2 arid1a sf3b1 uncover novel mutated genes including additional genes involved chromatin modification epc1 arid2 dna damage repair atm mechanisms zim2 map2k4 nalcn slc16a4 magea6 integrative analysis vitro functional data animal models provided supportive evidence potential roles genetic aberrations carcinogenesis pathway-based analysis recurrently mutated genes recapitulated clustering core signalling pathways pancreatic ductal adenocarcinoma identified new mutated genes pathway also identified frequent diverse somatic aberrations genes described traditionally embryonic regulators axon guidance particularly slit/robo signalling also evident murine sleeping beauty transposon-mediated somatic mutagenesis models pancreatic cancer providing supportive evidence potential involvement axon guidance genes pancreatic carcinogenesis
